Lv1
8 积分 2025-07-15 加入
Maturation of Tertiary Lymphoid Structures
1个月前
已完结
Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy
2个月前
已完结
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2个月前
已完结
Analysis of the Correlation and Prognostic Significance of Tertiary Lymphoid Structures in Breast Cancer: A Radiomics‐Clinical Integration Approach
6个月前
已完结
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
6个月前
已完结
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
6个月前
已完结
Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (TLS), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal Breast Carcinomas and Their Relationship with Prognostic Factors
6个月前
已完结
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
6个月前
已完结
Tertiary lymphoid structures in anticancer immunity
6个月前
已完结
Corrigendum to “Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023”
10个月前
已关闭
皖公网安备34019202002308
